A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicentre Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release (ER).
A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicentre Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release (ER).
Patients with overactive bladder are often treated with tolterodine, a medication that helps relax the bladder, helping symptoms of urinary incontinence and urinary frequency. Sometimes patients do not have a satisfactory response, and may benefit from trying an alternative oral medicine. Fesoterodine is related to tolterodine by producing the same active substance that acts on the bladder, but potentially at higher and more effective levels. So, a patient who has a poor response to tolterodine may still obtain a good response to fesoterodine. This study will help find out if this is what happens.
Inclusion Criteria:
Exclusion Criteria:
Fall River, Massachusetts 02720, United States
New Bedford, Massachusetts 02740, United States
Albany, New York 12208, United States
Pawtucket, Rhode Island 02860, United States
Barrie, Ontario L4M 7G1, Canada
Kingston, Ontario K7L 3J7, Canada
Kolin III, 28000, Czechia
Ústí nad Labem, 401 13, Czechia
Saint Petersburg, 196247, Russia
Dnipropetrovsk, 49005, Ukraine